← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

M 10b5-1 Plan

$ Value

$19K

Shares

12,500

Price

$2

Filed

Aug 22

Insider

Name

Scott Kathleen D.

Title

Chief Financial Officer

CIK

0001794284

Roles

Officer

Transaction Details

Transaction Date

2025-08-21

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,542

Footnotes

Includes 2,618 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2025. | The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 22, 2025. | Immediately exercisable.

Filing Info

Accession No.

0001415889-25-022760

Form Type

4

Issuer CIK

0001671858

Scott Kathleen D.'s History

Date Ticker Type Value
2026-01-02 SPRY A $0
2026-01-02 DRMA A $0
2025-08-21 SPRY M $19K
2025-08-21 SPRY $188K
2025-08-21 SPRY M $0
2025-05-20 SPRY M $75K
2025-05-20 SPRY $705K
2025-05-20 SPRY M $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.